Commercial Credit Report for Salix Pharmaceuticals, Ltd. (United States)

Preview

This is a Preview, click here for the full commercial credit report.

Salix Pharmaceuticals, Ltd.
1700, Perimeter Park Drive
Phone: (919) 862-1000	Morrisville, NC 27560 United States	Ticker: SLXP

Business Summary

Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company focuses on acquiring, developing and commercializing prescription drugs used in the treatment of a range of gastrointestinal diseases, which are those affecting the digestive tract. As of December 31, 2008, the Company�s products were XIFAXAN (rifaximin) Tablets 200 milligram; MOVIPREP; OSMOPREP, VISICOL Tablets, AZASAN Azathioprine Tablets, USP, 75/100 milligram; ANUSOL-HC 2.5% (Hydrocortisone Cream, USP), ANUSOL-HC 25 milligram Suppository (Hydrocortisone Acetate); PROCTOCORT Cream (Hydrocortisone Cream, USP) 1% and PROCTOCORT Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 milligram; PEPCID (famotidine) for Oral Suspension; Oral Suspension DIURIL (Chlorothiazide); APRISO (mesalamine) extended-release capsules 0.375 grams, and COLAZAL (balsalazide disodium) Capsules 750 milligram.

(Source: 10-K)

Financial Information

Financial Ratings:	Z'' Score FRISK Score
Latest Financial Statements and Analyses:	9/30/2009 Annual Financials Quarterly Financials
Current Fiscal Period:	3Q 2009
Fiscal Year End:	December
Last Audit:	12/31/2008
Auditors:	PricewaterhouseCoopers LLP
Audit Opinion:	Unqualified
Public Filings:	Suits & Judgments
Other Statements:	Trade Payment History
SEC Filings:	Management Discussion & Analysis Full Filings

Stock Performance

Industries

Type

Code

Description

Sector

HEALTH

Healthcare

Industry

BIOTRX

Biotechnology & Drugs

SIC

2834

Pharmaceutical Preparations

NAICS

325412

Pharmaceutical Preparation Manufacturing

Management

Title

Name

Age

Title Date

Start Date

Chairman of the Board

John F. Chappell

9/2/2003

12/1/1993

President, Chief Executive Officer, Director

Carolyn J. Logan

7/15/2002

6/14/2000

Chief Financial Officer, Senior Vice President - Finance and Administration

Adam C. Derbyshire

6/1/2000

5 additional Management records available in full report.

Business Names

Business Name

Corbec Pharmaceuticals, Inc.

Glycyx Pharmaceuticals, Ltd.

InKine Pharmaceutical Company, Inc.

Salix Pharmaceuticals, Inc.

Sangen Pharmaceutical Company

General Information

Number of Employees:	280	(As of 12/31/2008)
Outstanding Shares:	49,344,406	(As of 11/6/2009)
Shareholders:	234	(As of 12/31/2008)
Stock Exchange:	NASD
Federal Tax Id:	943267443
Fax Number:	(919) 862-1095
Email Address:	investor.relations@salixpharm.com